MUC2 and irritable bowel syndrome: We can hypothesize that sulfate-reducing bacteria play a significant role in modulating visceral pain in IBS by producing H2S. As such, the consumption of emulsifiers by IBS patients could increase gut barrier permeability and intestinal inflammation, with an increase in LPS and flagellin and a decrease in MUC2.